跳至主要内容
临床试验/NCT01645150
NCT01645150已完成不适用

Pilot Study on the Effects of Strength Training on Cancer Related Fatigue in Cancer Patients During Tyrosine Kinase Inhibitor Therapy

German Cancer Research Center2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2012年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
Change in cancer related fatigue

研究概览

简要总结

The purpose of this pilot study is to determine the effects of a 12-week resistance training program on cancer related fatigue in cancer patients receiving tyrosine kinase inhibitor (TKI) therapy. It is hypothesized that incidence and severity of cancer related fatigue can be reduced by exercise training in this population which leads to an improved treatment completion rate.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female cancer patients
  • Prior to tyrosine kinase inhibitor therapy (any substance, any line)
  • Age: at least 18 yrs
  • Body mass index (BMI): at least 18 kg/m2
  • ECOG performance status: at most 2
  • Must be able to meet the requirements of the study protocol

排除标准

  • Acute infectious diseases
  • No ambulatory ability
  • Severe neurological disorders
  • Severe cardiovascular diseases
  • Severe pulmonary insufficiency
  • Severe renal insufficiency
  • Other current tumor diseases
  • Conditions rendering compliance impossible
  • Participation in regular strength training

结局指标

主要结局

Change in cancer related fatigue

时间窗: From baseline to the 6th and 12th week of training.

Assessed via the Multidimensional Fatigue Inventory (MFI).

次要结局

  • Change in body composition(From baseline to the 12th week of training)
  • Change in muscle strength of the knee extensor, hip flexor and forearm flexor muscles.(From baseline to the 12th week of training.)
  • Change in quality of life(From baseline to the 6th and 12th week of training.)
  • Change in endurance capacity(From baseline to the 12th week of training.)
  • Change in depression(From baseline to the 6th and 12th week of training.)
  • Time of the first tumor progression under TKI therapy(Within the first 6 months of TKI therapy)
  • Time of reduction or replacement of TKI therapy(Within the first 6 months of TKI therapy)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验